These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9746856)

  • 1. Lymphocytes, cytokines, inflammation, and immune trafficking.
    Tsokos GC; Liossis SN
    Curr Opin Rheumatol; 1998 Sep; 10(5):417-25. PubMed ID: 9746856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytes, cytokines, inflammation, and immune trafficking.
    Tsokos GC; Kovacs B; Liossis SN
    Curr Opin Rheumatol; 1997 Sep; 9(5):380-6. PubMed ID: 9309192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytes, cytokines, inflammation, and immune trafficking.
    Tsokos GC
    Curr Opin Rheumatol; 1995 Sep; 7(5):376-83. PubMed ID: 8519609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes, cytokines, inflammation, and immune trafficking.
    Tsokos GC
    Curr Opin Rheumatol; 1996 Sep; 8(5):395-402. PubMed ID: 8941441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines play a central role in the pathogenesis of systemic lupus erythematosus.
    Singh AK
    Med Hypotheses; 1992 Dec; 39(4):356-9. PubMed ID: 1494323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytokines and lupus].
    Emilie D; Llorente L; Galanaud P
    Ann Med Interne (Paris); 1996; 147(7):480-4. PubMed ID: 9092358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
    Ezzat M; El-Gammasy T; Shaheen K; Shokr E
    Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus.
    Kaliyaperumal A; Mohan C; Wu W; Datta SK
    J Exp Med; 1996 Jun; 183(6):2459-69. PubMed ID: 8676066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytes, cytokines, inflammation, and immune trafficking.
    Tsokos GC
    Curr Opin Rheumatol; 1994 Sep; 6(5):461-7. PubMed ID: 7993702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T- and B-cell abnormalities in systemic lupus.
    Cohen PL
    J Invest Dermatol; 1993 Jan; 100(1):69S-72S. PubMed ID: 8423400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus nephritis: role of antinucleosome autoantibodies.
    van der Vlag J; Berden JH
    Semin Nephrol; 2011 Jul; 31(4):376-89. PubMed ID: 21839371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus].
    Guo Q; Chen XY; Su Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine models for systemic lupus erythematosus and Sjögren's syndrome.
    Mountz JD; Gause WC; Jonsson R
    Curr Opin Rheumatol; 1991 Oct; 3(5):738-56. PubMed ID: 1751309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against complement components in systemic lupus erythematosus - role in the pathogenesis and clinical manifestations.
    Hristova MH; Stoyanova VS
    Lupus; 2017 Dec; 26(14):1550-1555. PubMed ID: 29092674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity.
    Szyper-Kravitz M; Zandman-Goddard G; Lahita RG; Shoenfeld Y
    Rheum Dis Clin North Am; 2005 Feb; 31(1):161-75, x. PubMed ID: 15639061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
    Reininger L; Santiago ML; Takahashi S; Fossati L; Izui S
    Ann Med Interne (Paris); 1996; 147(7):467-71. PubMed ID: 9092356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell contribution of the CD4
    Choi SC; Morel L
    Autoimmunity; 2017 Feb; 50(1):37-41. PubMed ID: 28166683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.